Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin CRT in Newly Diagnosed Glioblastoma
NCT04677049Phase 2Active, not recruiting
- Sponsor
- American Health Staffing Group
- Start
- Mar 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in glioblastoma (GBM), sponsored by American Health Staffing Group. Started Mar 2021; status: active, not recruiting.
02
Drugs
niacin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04677049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677049.